Skip to content
Screener

Schering-Plough SGP Number of Exercisable Options

Number of Exercisable Options at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
4.2M+12.4%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M—
Total equity$250.1M+463%
Total assets$258.4M—

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$791.7M-5.2%
Enterprise value$554.41M—

Returns & leverage

See full
Return on equity-34.3%—
Debt / equity0×—
Current ratio38×—

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.

The source filing: Schering-Plough’s 10-K, filed March 26, 2026.

Filed
Mar 26, 2026, 5:23 PM EDT
Fiscal year
FY2025
Accession
0001778922-26-000020
Line itemOptionsWeighted Average Exercise PriceWeighted Average Remaining Contractual Life (Years)
Outstanding at December 31, 20253,405,906$4.648.79
Exercisable at December 31, 2025715,535$1.577.06

Item 8. [Financial Statements and Supplementary Data](#ifaf54775e85441fc836f60bc7c4f1464_4398046512509)

FAQ

What is Schering-Plough's number of exercisable options?
Schering-Plough (SGP) reported number of exercisable options of 715.5K in Q4 2025.
What does number of exercisable options mean?
The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.

Ask your AI about Schering-Plough's number of exercisable options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude